comparemela.com

Latest Breaking News On - ஜென்ஸ் க்ளீன் - Page 1 : comparemela.com

Origin Bio secures $15 million funding to help manufacturers create a more sustainable future

Origin.Bio a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes, freeing manufacturers from petrochemical dependency toda .

Sten tamkiviJens kleinCharlie songhurstTaavet hinrikusGregory bernsteinBlueyard capitalAcequia capitalOrigin bioVenture leadSynthetic biologyYnthetic microorganismsஜென்ஸ் க்ளீன்கிரெகொரி பெர்ன்ஸ்டீன்அஸ்குட்ட மூலதனம்துணிகர வழி நடத்துசெயற்கை உயிரியல்

Today in European Tech: EU to launch antitrust probe into Facebook, Contentsquare lands $500 million, and more

Today in European Tech: EU to launch antitrust probe into Facebook, Contentsquare lands $500 million, and more
tech.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tech.eu Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomCity ofUnited kingdom generalComunidad autonoma de catalunaEze vidraTed perssonRandy buddChris obrienJens kleinFred lardiegKieran olearyRob moffatColin hannaFred lardieg fredlardiegOscar pierre

This Company Is Freeing Manufacturers From Petrochemicals With Biology

Origin.Bio announced today that it has secured $15 million of funding led by EQT Ventures. The company plans to use the funding to expand technology and bring sustainable ingredients to brands all over the world.

United statesJens kleinEuropean unionOrigin bioClimate changeClimate crisisClimate emergencyBio basedSynthetic biologyஒன்றுபட்டது மாநிலங்களில்ஜென்ஸ் க்ளீன்ஐரோப்பிய தொழிற்சங்கம்உயிரி தொழில்நுட்பவியல்பெட்ரோ கெமிக்கல்ஸ்காலநிலை மாற்றம்காலநிலை நெருக்கடி

Origin Bio Raises $15M in Funding

Origin.Bio, a Munich, Germany-based synthetic biology company, raised $15m in funding. The round was led by EQT Ventures with participation from existing investor BlueYard Capital and new investors Taavet Hinrikus and Sten Tamkivi, Acequia Capital, Inventures and Charlie Songhurst. The company intends to use the funds to expand the technology and team. Founded by Jens Klein, CEO, Origin.Bio is a synthetic biology company which creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialisation processes but with less energy requirements and waste produced. FinSMEs 26/05/2021

Sten tamkiviJens kleinCharlie songhurstTaavet hinrikusOrigin bioBlueyard capitalAcequia capitalஜென்ஸ் க்ளீன்அஸ்குட்ட மூலதனம்

vimarsana © 2020. All Rights Reserved.